We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About MSK MyChart

MSK MyChart (formerly MyMSK) is the patient portal for MSKCC.

MSK MyChart (formerly MyMSK) is for patients receiving care at Memorial Sloan Kettering Cancer Center.

MSK MyChart, our patient portal, is the best way to stay connected to your healthcare. Patients and caregivers can download and log in to the MSK MyChart app to securely:

• See your medical information.

• View and share your test results.

• Manage your appointments.

• Save appointment details to your calendar on your mobile device.

• Connect to telemedicine visits.

• Message your care team.

• Connect your accounts from other healthcare centers so you can see all your medical information in one place.

• Request prescription refills.

• Fill out health questionnaires.

• Read patient education information.

• View and pay bills.

You can create an MSK MyChart account on the app or at MSKMyChart.MSK.org using your activation code. To get an activation code, please ask someone from your doctor’s office or call our Help Desk at 800-248-0593.

What's New in the Latest Version 11.1.3

Last updated on Feb 7, 2025

MSK MyChart (formerly MyMSK) is the patient portal for Memorial Sloan Kettering Cancer Center. Miscellaneous fixes and improvements.

Translation Loading...

Additional APP Information

Latest Version

Request MSK MyChart Update 11.1.3

Uploaded by

Abdelrahman Salem

Requires Android

Android 9.0+

Available on

Get MSK MyChart on Google Play

Show More

MSK MyChart Screenshots

Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.